Cathie Wood stocks have done well in the past few months, with the ARK Innovation ETF (ARKK) soaring by 72% to $64. It has ...

Legendary fund manager Cathie Wood isn’t typically associated with boring, dividend-paying companies. Known for picking up ...

Cathie Wood and Ark Invest sold roughly $7,379,804 worth of Palantir stock — and spent $9,145,824 on three biotech stocks.

Low-cost passive index investing (in the S&P 500 or Nasdaq 100) has been key to impressive results in recent years. However, with much of the outsized gains coming from just a handful of names (at the ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

Explore Cathie Wood's latest investment insights on the convergence of artificial intelligence in shaping the future, as ...

EST Cathie Wood’s ARK Investment buys 77.6K shares of 10x Genomics (TXG) todayMaximize Your Portfolio with Data Driven Insights:Leverage ...

For the bulls, investors may consider the Direxion Daily PLTR Bull 2X Shares PLTU. A leveraged exchange-traded fund, PLTU seeks 200% of the daily leveraged investment results of the namesake security.

EST Cathie Wood’s ARK Investment buys 187K shares of Crispr Therapeutics (CRSP) todayMaximize Your Portfolio with Data Driven ...

While Ethereum has a phenomenal historical track record, investors should be aware that new blockchain competitors continue ...

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...